Outcome of WHO survey on reliance

Submitted by c.angulo on Fri, 06/21/2019 - 13:56
A focus topic of the IPRP MC meeting in Amsterdam, the Netherlands, on 2-3 June 2019, was reliance, the act by which one regul

IDMP FAQ

Submitted by c.angulo on Tue, 06/18/2019 - 09:40
The Working Group on Identification of Medicinal Products (IDMP) has published a Frequently Asked Questions (FAQ) document

IPRP - 3rd Meeting - Public Statement

Submitted by c.angulo on Fri, 06/14/2019 - 15:32
The third meeting of the International Pharmaceutical Regulators Programme (IPRP) Management Committee (MC) was held on the 2nd and 3rd of

New templates from the BEWGG

Submitted by c.angulo on Thu, 02/07/2019 - 16:15
To complement the template developed by the BEWGG for Biopharmaceutics Classification System (BCS) Biowaivers Assessment Reports, a tem

IPRP Stakeholder Engagement Plan

Submitted by c.angulo on Thu, 12/06/2018 - 16:58
While maintaining its focus as a forum for regulators to share best practices and experiences, IPRP is also committed to engage with it